| 1. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
| 2. | | Recruiting | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Conditions: recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus |
| 3. | | Recruiting | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 4. | | Recruiting | Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 5. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 6. | | Recruiting | Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
| 7. | | Recruiting | BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer |
| 8. | | Recruiting | BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 9. | | Recruiting | CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 10. | | Recruiting | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma |
| 11. | | Recruiting | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; ... |
| 12. | | Recruiting | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ... |
| 13. | | Not yet recruiting | FR901228 in Treating Patients With Advanced Colorectal Cancer That Has Progressed After a Previous Fluorouracil-Containing Regimen
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 14. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 15. | | Not yet recruiting | FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 16. | | Recruiting | Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Conditions: stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; Drug Toxicity |
| 17. | | Recruiting | Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 18. | | Recruiting | Imatinib Mesylate in Treating Patients With Myelofibrosis
Conditions: Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia; Chronic Myelomonocytic Leukemia |
| 19. | | Recruiting | Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 20. | | Recruiting | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma |
| 21. | | Recruiting | Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 22. | | Recruiting | Vaccine Therapy in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 23. | | Recruiting | XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
